Summit Therapeutics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
9.84 |
34.46 |
26.35 |
127.41 |
911.31 |
2,281.89 |
| Przychód Δ r/r |
0.00% |
250.32% |
-23.54% |
383.55% |
615.28% |
150.40% |
| Przychód (min) |
-0.02 |
-0.07 |
-69.99 |
125.20 |
-1.78 |
-4.46 |
| Przychód (max) |
33.85 |
118.58 |
261.07 |
129.61 |
3,135.89 |
7,852.12 |
| EBITDA (średnia) |
-1.97 |
-6.89 |
-5.27 |
-25.48 |
-182.26 |
-456.38 |
| EBIT (średnia) |
-1.97 |
-6.89 |
-5.27 |
-25.48 |
-182.26 |
-456.38 |
| EBIT % |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-240.75 |
-230.50 |
-307.76 |
-441.97 |
97.48 |
837.80 |
| Zysk netto % |
-2447.49% |
-668.89% |
-1168.03% |
-346.89% |
10.70% |
36.72% |
| EPS (średnia) |
-0.62 |
-0.32 |
-0.42 |
-0.45 |
0.14 |
1.17 |
| Liczba analityków (Przychody) |
4 |
6 |
11 |
10 |
4 |
5 |
| Liczba analityków (EPS) |
3 |
5 |
6 |
6 |
3 |
4 |
| symbol |
SMMT |
SMMT |
SMMT |
SMMT |
SMMT |
SMMT |